According to a new report by UnivDatos, The Embolotherapy Market is expected to reach USD million in 2033 by growing at a CAGR of 8.1%. The embolotherapy market is increasing because the target diseases, like liver cancer, uterine fibroids, and arteriovenous malformations, are increasingly being treated using minimally invasive procedures. The evolution of embolic agents is on...